Close Menu

NEW YORK — Antibody testing for SARS-CoV-2 remains inappropriate for guiding individuals' decision-making about the ongoing pandemic, in part due to the presence of ineffective tests on the market, a panel of four medical experts said during a congressional subcommittee hearing held on Tuesday by video.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.